3-38728741-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_006514.4(SCN10A):c.2441G>A(p.Arg814His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,614,142 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R814C) has been classified as Uncertain significance.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.2441G>A | p.Arg814His | missense_variant | Exon 16 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.2441G>A | p.Arg814His | missense_variant | Exon 15 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.2468G>A | p.Arg823His | missense_variant | Exon 16 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000279 AC: 70AN: 250764 AF XY: 0.000206 show subpopulations
GnomAD4 exome AF: 0.000486 AC: 711AN: 1461882Hom.: 1 Cov.: 31 AF XY: 0.000448 AC XY: 326AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000394 AC: 60AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74430 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:6
- -
p.Arg814His (c.2441G>A) in exon 15 of the SCN10A gene (NM_006514.3) Chromosome position: 3:38770232 C / T Found in a male patient with early-onset lone atrial fibrillation. The SCN10A gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with Brugada syndrome (BrS) (PMID: 24998131). Based on the information reviewed below, including this variant’s prevalence in population databases, and how poorly conserved this residue is across evolution, we classify it as a Variant of Uncertain Significance, Probably Benign, concluding that there is not sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing. This variant has been reported in 4 probands: 3 affected with early-onset atrial fibrillation (2 from Savio-Galimberti et al., 2014, PMID: 25053638; and 1 from Jabbari et al., 2015, PMID: 25691686) and 1 with arrhythmogenic right ventricular dysplasia/cardiomyopathy (Te Riele et al., 2016, PMID: 26733327). All reported individuals also carried another change (c.472T>G, p.Tyr158Asp) that was shown to be on the same allele (in cis) in at least three of these cases (Savio-Galimberti et al., 2014, PMID: 25053638; Te Riele et al., 2016, PMID 26733327). Savio-Galimberti et al. (2014) report that in their two families, first degree relatives with the variant(s) did not show atrial fibrillation, possibly due to reduced penetrance. This is a conservative amino acid change, resulting in the replacement of a positively-charged Arginine with a positively-charged Histidine. Arginine at this location is very poorly conserved across ~100 vertebrate species for which we have data. There is no Likely Pathogenic or Pathogenic missense variant currently listed in ClinVar at a nearby residue (+/- 10). Experimental studies in vitro have shown that this missense change generates a peak current that is 4 times larger than that of wild type (Savio-Galimberti et al., 2014; PMID: 25053638). This variant was reported in 85 individuals in the gnomAD database, which includes ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. (MAF = 0.03%.) Specifically, the variant was observed in 63 individuals with non-Finnish European ancestry (for the highest allele frequency: 0.05%), and 7 individuals with Latino ancestry, 5 African ancestry, 4 Finnish ancestry, 3 South Asian ancestry, and 3 “Otherâ€. Our patient’s ancestry is Latino. This variant is present at a higher frequency than would be expected for a pathogenic variant. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -
- -
Reported in individuals with atrial fibrillation, arrhythmogenic right ventricular cardiomyopathy (ARVC), AV nodal reentrant tachycardia, or diabetic peripheral neuropathy, many of whom also harbored the p.(Y158D) variant in the SCN10A gene in either cis or unknown configuration (PMID: 25053638, 25691686, 26733327, 28407228, 29396561, 31638414); Published functional studies demonstrated that p.(R814H) generates a peak sodium current approximately four times larger than wild-type SCN10A channels, and when co-expressed with p.(Y158D), the magnitude of the peak current was close to the sum of the average value of the peak currents of each variant expressed individually, such that both variants are reported to contribute to the electrical property of the channel; however, additional studies are needed to validate the functional effect of this variant in vivo (PMID: 25053638); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28407228, 25691686, 26733327, 31638414, 29396561, 34426522, 37175987, 25053638) -
- -
- -
not specified Uncertain:1
Variant summary: SCN10A c.2441G>A (p.Arg814His) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00048 in 1607170 control chromosomes, predominantly at a frequency of 0.00058 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. This frequency is not higher than the estimated maximum for a pathogenic variant in SCN10A, allowing no conclusion about variant significance. Of note, this variant is typically reported in the literature as a complex (i.e. on the same allele) with c.472T>G (p.Tyr158Asp), and variant co-occurrence analysis in gnomAD indicates that these two missense variants are on the same haplotype in most individuals. The two missense variants, c.472T>G (p.Tyr158Asp) and c.2441G>A (p.Arg814His), has been observed together in individuals affected with SCN10A-Related Disorders, including arrhythmia and neuropathy, however no segregation evidence was provided to support causality (e.g. Savio-Galimberti_2014, Jabbari_2015, TeRiele_2016, Almomani_2023). At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated that both missense variants in isolation and together as a complex, affected sodium channel function, resulting in increased currents, and the two missense seemed to result in an additive effect when expressed together (Savio-Galimberti_2014), however, these results do not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 25053638, 25691686, 26733327, 37175987). ClinVar contains an entry for this variant (Variation ID: 420025). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Brugada syndrome 1 Uncertain:1
- -
Episodic pain syndrome, familial, 2 Uncertain:1
- -
Brugada syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at